Ânima Subsidiary Inspirali Signs 20-Year Medical Education Consulting Deal With Einstein

By Public Technologies
  • Ânima Holding subsidiary Inspirali signed a 20-year medical education consulting agreement with Einstein, renewable automatically for another 20 years.
  • Fixed fees total BRL 150 million: BRL 75 million upfront, the remainder due in one year, adjusted for inflation.
  • Einstein will receive 6% of net revenue from new students entering medical degree classes starting from signing, calculated and paid quarterly.
  • Contingent annual payments apply during 2027-2036 if commissions fall below contractual reference amounts, subject to inflation-adjusted caps.
  • The initial BRL 75 million payment raises Ânima’s pro forma leverage to 2.47 times from 2.41 times reported in second-quarter 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anima Holding SA published the original content used to generate this news brief on October 19, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.